pharmaceutical-investing PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million
pharmaceutical-investing PreveCeutical Provides Update on Visit to Penta 5 Group’s Facility for Due Diligence on Proposed Acquisition
Anteros Metals Announces Plans for a Phase 1 Extension Drilling Program at the Seagull Critical Minerals Project, Ontario
Kobo Resources Extends Gold Mineralisation at Depth and Further Defines the Contact Zone Fault Target
